Safety pharmacology of self-assembled-micelle inhibitory RNA-targeting amphiregulin (SAMiRNA-AREG), a novel siRNA nanoparticle platform.

Kim, Tae Rim; Kim, Hyeon-Young; Kim, In-Hyeon; Kim, Ki Cheon; Ko, Youngho; Park, Jun Hong; Yun, Sungil; Lee, In-Chul; Kim, Sung-Hwan; Park, Han-Oh.

Afiliación

Kim TR; siRNAgen Therapeutics and Bioneer Corporation, Daejeon, 34302, Republic of Korea.
Kim HY; Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, 56212, Republic of Korea.
Kim IH; Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, 56212, Republic of Korea.
Kim KC; Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, 56212, Republic of Korea.
Ko Y; siRNAgen Therapeutics and Bioneer Corporation, Daejeon, 34302, Republic of Korea.
Park JH; siRNAgen Therapeutics and Bioneer Corporation, Daejeon, 34302, Republic of Korea.
Yun S; siRNAgen Therapeutics and Bioneer Corporation, Daejeon, 34302, Republic of Korea.
Lee IC; Functional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, 56212, Republic of Korea.
Kim SH; Jeonbuk Branch Institute, Korea Institute of Toxicology, Jeongeup, 56212, Republic of Korea.
Park HO; siRNAgen Therapeutics and Bioneer Corporation, Daejeon, 34302, Republic of Korea.